Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fateh

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|December 1, 1992
Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinomaP Stieber, D Nagel, C Ritzke, et al.
Science (New York, N.Y.)|August 28, 1981
Myeloma neuropathy: passive transfer from man to mouseU A Besinger, K V Toyka, A P Anzil, et al.
Anticancer Research|July 1, 1997
Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinomaW Reiter, P Stieber, C Reuter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2012
HSP65-PRA identification of non-tuberculosis mycobacteria from 4892 samples suspicious for mycobacterial infectionsM Saifi, E Jabbarzadeh, A R Bahrmand, et al.
Journal of Microbiological Methods|September 8, 2011
Purification of modified mycobacterial A60 antigen by affinity chromatography and its use for rapid diagnostic tuberculosis infectionSh Yari, A Hadizadeh Tasbiti, A Fateh, et al.
British Journal of Haematology|July 1, 1982
Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and stagingR Bartl, B Frisch, R Burkhardt, et al.
Anticancer Research|September 2, 1999
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysisF C Ebeling, U M Schmitt, M Untch, et al.
Urology|August 1, 1995
Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancerC M Schambeck, N Schmeller, P Stieber, et al.
Deutsche Medizinische Wochenschrift (1946)|September 10, 1971
[Effect of heterologous antilymphocyte globulin in chronic lymphoid leukemia]H Pfisterer, K Lani, K Demmler, et al.
Clinical Biochemistry|August 1, 1993
Cytokeratin 19 fragments: a new marker for non-small-cell lung cancerP Stieber, H Bodenmüller, D Banauch, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|December 1, 1992
Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinomaP Stieber, D Nagel, C Ritzke, et al.
Science (New York, N.Y.)|August 28, 1981
Myeloma neuropathy: passive transfer from man to mouseU A Besinger, K V Toyka, A P Anzil, et al.
Anticancer Research|July 1, 1997
Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinomaW Reiter, P Stieber, C Reuter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2012
HSP65-PRA identification of non-tuberculosis mycobacteria from 4892 samples suspicious for mycobacterial infectionsM Saifi, E Jabbarzadeh, A R Bahrmand, et al.
Journal of Microbiological Methods|September 8, 2011
Purification of modified mycobacterial A60 antigen by affinity chromatography and its use for rapid diagnostic tuberculosis infectionSh Yari, A Hadizadeh Tasbiti, A Fateh, et al.
British Journal of Haematology|July 1, 1982
Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and stagingR Bartl, B Frisch, R Burkhardt, et al.
Anticancer Research|September 2, 1999
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysisF C Ebeling, U M Schmitt, M Untch, et al.
Urology|August 1, 1995
Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancerC M Schambeck, N Schmeller, P Stieber, et al.
Deutsche Medizinische Wochenschrift (1946)|September 10, 1971
[Effect of heterologous antilymphocyte globulin in chronic lymphoid leukemia]H Pfisterer, K Lani, K Demmler, et al.
Clinical Biochemistry|August 1, 1993
Cytokeratin 19 fragments: a new marker for non-small-cell lung cancerP Stieber, H Bodenmüller, D Banauch, et al.
Pageof 15